Cite
HARVARD Citation
Seligson, J. et al. (2021). Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer. Annals of pharmacotherapy. 55 (7), pp. 921-931. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Seligson, J. et al. (2021). Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer. Annals of pharmacotherapy. 55 (7), pp. 921-931. [Online].